AUTONOMIC NEUROPATHY IN DIABETES MELLITUS: CLINICAL MANIFESTATIONS, DIAGNOSIS AND TREATMENT


Cite item

Full Text

Abstract

The article is dedicated to the problem of autonomic neuropathy, which may be caused by variety of etiological factors. The most common cause of autonomic neuropathy (AN) is diabetes mellitus, and disability and death in diabetic patients are mainly due to cardiovascular complications of AN. The clinical characteristics of cardiovascular AN, methods of diagnosis and principles of treatment of autonomic dysfunction are presented. The treatment of AN is a complex medico-social problem that requires maximum participation of the patient in the treatment, as well as the creation of necessary conditions for rehabilitation against the background of the pathogenetic (tioctic acid) and symptomatic (mineralocorticoides, sympathomimetics) therapy.

References

  1. Аметов А.С., Строков И.А., Баринов А.Н., и др: Альфа-липоевая кислота в лечении симптомной диабетической полиневропатии: symptomatic diabetic neuropathy (SYDNEY) trial // Фарматека. 2004. № 11(88). C. 69-73.
  2. Баринов А.Н., Строков И.А. Диабетическая невропатия // Неврологический журнал. 2000. Т 5. № 5. С. 47-55.
  3. Котов С.В., Калинин А.П., Рудакова И.Г. Диабетическая невропатия. М., 2000. С. 71.
  4. Прихожан В.М. Нарушения иннервации внутренних органов при сахарном диабете // Сов. Медицина 1978. № 6. С. 99-104.
  5. Прихожан В.М. Особенности развития диабетической невропатии в зависимости от пола больных сахарным диабетом // Пробл. Эндокринологии. 1977. Т. 23. № 5. С. 11-6.
  6. Прихожан В.М. Поражение нервной системы при сахарном диабете. М., 1981. С. 296.
  7. Строков И.А., Баринов А.Н., Новосадова М.В., Яхно Н.Н. Клинические методы оценки тяжести диабетической полиневропатии // Неврологический журнал. 2000. Т 5. № 5. С. 14-9.
  8. Строков И.А., Манухина Е.Б., Бахтина Л.Ю., с соавт. Состояние эндогенных протекторных систем у больных с инсулинзависимым сахарным диабетом с полиневропатией: эффект антиоксидантной терапии // Бюллетень экспериментальной биологии и медицины. 2000. Т 130. № 10. С. 437-41.
  9. Табеева Г.Р., Азимова Ю.Э. Антиоксидантная терапия диабетической полинейропатии // Фарматека 2010. № 7(201). C. 48-52.
  10. Anan F. Diabetic retinopathy is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Hypertens Res 2009;32(4):299-05.
  11. Collado Marquez S. Diabetic autonomic neuropathy diagnosed in primary care in patients with type 2 diabetes. Aten Primaria 2008;40(10):511-5.
  12. Dyck PJ, Ametov AS, Barinov AN, et al: The sensory symptoms of diabetic polyneuropathy are improved with a-lipoic acid. Diabetes Care 2003;26(3):770-6.
  13. Elliott J. Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors. Diabetes Care 2009;32(10):1896-900.
  14. Ewing DJ, Martin CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985;8:491-8
  15. Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetic Control and Complications Trial (DCCT). Diabetes. 1988;37:476-81.
  16. Freeman R. Autonomic Peripheral Neuropathy. Neurol Clin. 2007;25(1):277-301.
  17. Grant. JA, O'Brien P, Dyck PJ. Neuropathy test and normative results. Diabetic Neuropathy. Philadelphia. 1999:123-34.
  18. Javorka M. Recurrences in heart rate dynamics are changed in patients with diabetes mellitus. Clin Physiol Funct Imaging. 2008;28(5):326-31.
  19. Lacigov AS. Could we predict asymptomatic cardiovascular autonomic neuropathy in type 1 diabetic patients attending out-patients clinics? Wien Klin Wochenschr 2007;119(9-10):303-8.
  20. Lacigova S. Influence of cardiovascular autonomic neuropathy on atherogenesis and heart function in patients with type 1 diabetes. Diabetes Res Clin Pract 2009;83(1):26-31.
  21. Lambrecht R. Evaluation of a brief cardiovascular autonomic screen. Auton Neurosci 2007;131(1-2):102-6.
  22. Low PA, Walsh JC, Huang CY, et al. The sympathetic nervous system in diabetic neuropathy: a clinical and pathological study. Brain 1975;98:341-56.
  23. Maser RE, Mitchell BD, Vinik AI, et al. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003;26(6):1895-901.
  24. Maser RE, Pfeifer MA, Dorman JS, et al. Diabetic autonomic neuropathy and cardiovascular risk: Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med 1990;150:1218-22.
  25. Ninkovic AV. Cardiovascular autonomous dysfunction in diabetics: the influence of disease duration, glycoregulation degree and diabetes type. 2008;136(9-10):488-93.
  26. Rabbone I. Early cardiovascular autonomic dysfunction, beta cell function and insulin resistance in obese adolescents. Acta Biomed 2009;80(1):29-35.
  27. Rathmann W, Ziegler D, Jahnke M, et al. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993;10(9):820-4.
  28. Schmid H. Cardiovascular impact of the autonomic neuropathy of diabetes mellitus. Arq Bras Endocrinol Metabol 2007;51(2):232-43.
  29. Sun PC. Thermoregulatory sudomotor dysfunction and diabetic neuropathy develop in parallel in at-risk feet. Diabet Med 2008;25(4):413-8.
  30. Szabo L. Urinary flow disturbance as an early sign of autonomic neuropathy in diabetic children and adolescents. Neurourol Urodyn 2007;26(2):218-21.
  31. Tavakoli M. Corneal confocal microscopy: a novel means to detect nerve fibre damage in idiopathic small fibre neuropathy. Exp Neurol 2010;223(1):245-50.
  32. Tesfaye S. Advances in the management of diabetic peripheral neuropathy. Curr Opin Support Palliat Care 2009;3(2):136-43.
  33. Wheeler T, Watkins PJ. Cardiac denervation in diabetes. Br Med J 1973;4:584-6.
  34. Ziegler D. Effects of treatment with the antioxidant alfa-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. Diabetes Care 1997;20(3):369-73.
  35. Ziegler D, Ametov AS, Barinov AN, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2007;29:2365-70.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies